Paper7850784
Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
Gao J and 5 others. Cancer Res, 1995. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. Papers, record 7850784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7850784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, Tumor Suppressor | Major topic |
| von Hippel-Lindau Disease | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Blotting, Northern | |
| Cloning, Molecular | |
| DNA Probes | |
| DNA, Complementary | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Open Reading Frames | |
| RNA, Messenger | |
| Sequence Homology, Nucleic Acid |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41198931 | Oncostatin M induces epigenetic reprogramming in renal cell carcinoma-associated endothelial cells. | Commun Biol | 2025 | https://conductscience.org/library/papers/41198931 | PubMed |
| 21996733 | Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms. | Oncogene | 2012 | https://conductscience.org/library/papers/21996733 | PubMed |
| 18095884 | VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. | Expert Rev Anticancer Ther | 2008 | https://conductscience.org/library/papers/18095884 | PubMed |
| 12844285 | Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. | Am J Hum Genet | 2003 | https://conductscience.org/library/papers/12844285 | PubMed |
| 11420685 | Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. | Oncogene | 2001 | https://conductscience.org/library/papers/11420685 | PubMed |
| 11173562 | Recessive oncogenes: current status. | Pathol Oncol Res | 1995 | https://conductscience.org/library/papers/11173562 | PubMed |
| 10761708 | Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families. | Jpn J Cancer Res | 2000 | https://conductscience.org/library/papers/10761708 | PubMed |
| 10102622 | Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity. | Oncogene | 1999 | https://conductscience.org/library/papers/10102622 | PubMed |
| 9751722 | pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9751722 | PubMed |
| 9671762 | A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9671762 | PubMed |
| 9256442 | Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9256442 | PubMed |
| 9205944 | The molecular basis of von Hippel-Lindau disease. | Mol Med | 1997 | https://conductscience.org/library/papers/9205944 | PubMed |
| 8700833 | Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8700833 | PubMed |
| 7604013 | Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7604013 | PubMed |
| 7493907 | Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. | Jpn J Cancer Res | 1995 | https://conductscience.org/library/papers/7493907 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | S76748 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7850784
GET https://conductscience.org/api/papers/v1/7850784/authors